Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

Key points are not available for this paper at this time.

NCT01532869; Post-results.

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Denton et al. (Thu,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: